BSD GROWTH

Description

BSD Growth is a self managed Investment Vehicle that operates sub funds. The 1st sub-fund: BSD LIFE SCIENCES first closing is set at €50M.A 2nd sub-fund closing is planned with the collaboration of the Polish Government at €100M – with a leverage of 3 in R&D for every invested Euro which will enable continued investments in the targets towards an exit / IPO. BSD Life Science Fund is an attractive deal pipeline (mostly in Israel and Poland) and proprietary access to Life Science based investment opportunities. They have a unique team of seasoned professionals and expert advisers with great track record and a business model with high performance expectations. Abraham Biderman Chairman BSD Growth Managing Director of Palladium Capital Advisors, LLC. Adam Tuvia Ofek Senior Partner Director of M&A and Corporate Finance BSD Growth Fund Davies Guttmann Director & Investor Relations BSD Growth Tevy Troy Partner Senior Adviser to BSD Growth Fund Yehuda Lanzkron Partner Corporate Director Benjy Cuby EIF Director Head of Business Development Yochanan Bukshpan Partner Business Development Director

AI Sector Summary

BSD Growth focuses primarily on life sciences and biotech R&D opportunities, specifically targeting investments in Israel and Poland.

Financials